Cabozantinib most promising for refractory metastatic kidney cancer
In a European study of second-line treatments for metastatic kidney [...]
In a European study of second-line treatments for metastatic kidney [...]
Results from a phase 2 study of pazopanib alternated with [...]
There is increasing interest in using treatment breaks to reduce [...]
Pazopanib is used for first-line metastatic RCC treatment, but the [...]
A recent post hoc analysis of the results from the [...]
A recent literature review and network meta-analysis of phase 2/3 [...]
A retrospective study of the use of targeted therapies for [...]
A study published in Clinical Genitourinary Cancer last month describes [...]
Non-clear cell renal cell carcinoma (RCC) and sarcomatoid renal cell [...]
The following video interview with Dr Elizabeth Plimack from the [...]